Probi's Annual Report and Sustainability Report for 2019 are now available on the company website, www.probi.com under Investor Relations.
This information is information that Probi AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 14.00 CET on 8 April 2020.
FOR FURTHER INFORMATION, CONTACT:
Henrik Lundkvist, CFO, Probi, tel +46 46 286 89 41, e-post: firstname.lastname@example.org
Probi AB is a Swedish publicly traded bioengineering company. Probi's vision is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Founded by scientists in Sweden in 1991, Probi is a multinational company, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2019, Probi had net sales of MSEK 626. The Probi share is listed on Nasdaq Stockholm, Mid Cap. Probi had about 4,000 shareholders on December 31, 2019. Read more at www.probi.com.
This information was distributed by Cision http://www.cisionwire.se/